Mainz Biomed
MYNZ
#9822
Rank
$6.26 M
Marketcap
$0.24
Share price
-3.92%
Change (1 day)
-87.81%
Change (1 year)

P/E ratio for Mainz Biomed (MYNZ)

P/E ratio as of October 2024 (TTM): -0.1283

According to Mainz Biomed's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.128272. At the end of 2022 the company had a P/E ratio of -3.82.

P/E ratio history for Mainz Biomed from 2023 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-3.82-41.44%
2021-6.52

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.